Rosuvastatin Improves Vaspin Serum Levels in Obese Patients with Acute Coronary Syndrome

@inproceedings{AlKuraishy2018RosuvastatinIV,
  title={Rosuvastatin Improves Vaspin Serum Levels in Obese Patients with Acute Coronary Syndrome},
  author={Hayder M Al-Kuraishy and Ali Ismail A Al-Gareeb and Ali K. Al-buhadilly},
  booktitle={Diseases},
  year={2018}
}
Adipose tissue-derived serine protease inhibitor (vaspin), which has endocrine and local roles in atherosclerosis growth, is also synthesized by adipose tissue; it was found that vaspin was negatively correlated with blood pressure in obese patients, while vaspin levels were decreased in endothelial dysfunction. The aim of the present study was to determine rosuvastatin modulation effects on serum vaspin levels in acute coronary syndrome (ACS) with class I obesity. A total number of seventy… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 37 references

New Insights into the Role of Metformin Effects on Serum Omentin1 Levels in Acute MyocardialInfarction: Cross-Sectional Study

  • H. M. Al-Kuraishy, A. I. Al-Gareeb
  • Emerg. Med. Int
  • 2015
1 Excerpt

Similar Papers

Loading similar papers…